Skip Navigation



Brain Advance Access published online on May 6, 2009

Brain, doi:10.1093/brain/awp102
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
132/7/1866    most recent
awp102v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dreier, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dreier, J. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

Jens P. Dreier1,2,3, Sebastian Major1,2,3, Andrew Manning4, Johannes Woitzik3,5, Chistoph Drenckhahn1,2,3, Jens Steinbrink3, Christos Tolias4, Ana I. Oliveira-Ferreira1,3, Martin Fabricius6, Jed A. Hartings7, Peter Vajkoczy3,5, Martin Lauritzen6, Ulrich Dirnagl1,3, Georg Bohner3,8, Anthony J. Strong4 and for the COSBID study group

1 Department of Experimental Neurology, Charité University Medicine Berlin, Berlin, Germany 2 Department of Neurology, Charité University Medicine Berlin, Berlin, Germany 3 Center for Stroke Research Berlin, Charité University Medicine Berlin, Berlin, Germany 4 Department of Clinical Neuroscience, King's College London, London, UK 5 Department of Neurosurgery, Charité University Medicine Berlin, Berlin, Germany 6 Department of Clinical Neurophysiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark 7 Department of Neurosurgery, University of Cincinnati, Cincinnati, OH, USA 8 Department of Neuroradiology, Charité University Medicine Berlin, Berlin, Germany

Correspondence to: Jens P. Dreier, Center for Stroke Research Berlin, Charité Campus Mitte, Charité University Medicine Berlin, Charitépl. 1, 10117 Berlin, Germany E-mail: jens.dreier{at}charite.de

The term cortical spreading depolarization (CSD) describes a wave of mass neuronal depolarization associated with net influx of cations and water. Clusters of prolonged CSDs were measured time-locked to progressive ischaemic damage in human cortex. CSD induces tone alterations in resistance vessels, causing either transient hyperperfusion (physiological haemodynamic response) in healthy tissue; or hypoperfusion [inverse haemodynamic response = cortical spreading ischaemia (CSI)] in tissue at risk for progressive damage, which has so far only been shown experimentally. Here, we performed a prospective, multicentre study in 13 patients with aneurysmal subarachnoid haemorrhage, using novel subdural opto-electrode technology for simultaneous laser-Doppler flowmetry (LDF) and direct current-electrocorticography, combined with measurements of tissue partial pressure of oxygen (ptiO2). Regional cerebral blood flow and electrocorticography were simultaneously recorded in 417 CSDs. Isolated CSDs occurred in 12 patients and were associated with either physiological, absent or inverse haemodynamic responses. Whereas the physiological haemodynamic response caused tissue hyperoxia, the inverse response led to tissue hypoxia. Clusters of prolonged CSDs were measured in five patients in close proximity to structural brain damage as assessed by neuroimaging. Clusters were associated with CSD-induced spreading hypoperfusions, which were significantly longer in duration (up to 144 min) than those of isolated CSDs. Thus, oxygen depletion caused by the inverse haemodynamic response may contribute to the establishment of clusters of prolonged CSDs and lesion progression. Combined electrocorticography and perfusion monitoring also revealed a characteristic vascular signature that might be used for non-invasive detection of CSD. Low-frequency vascular fluctuations (LF-VF) (f < 0.1 Hz), detectable by functional imaging methods, are determined by the brain's resting neuronal activity. CSD provides a depolarization block of the resting activity, recorded electrophysiologically as spreading depression of high-frequency-electrocorticography activity. Accordingly, we observed a spreading suppression of LF-VF, which accompanied spreading depression of high-frequency-electrocorticography activity, independently of whether CSD was associated with a physiological, absent or inverse haemodynamic response. Spreading suppressions of LF-VF thus allow the differentiation of progressive ischaemia and repair phases in a fashion similar to that shown previously for spreading depressions of high-frequency-electrocorticography activity. In conclusion, it is suggested that (i) CSI is a novel human disease mechanism associated with lesion development and a potential target for therapeutic intervention in stroke; and that (ii) prolonged spreading suppressions of LF-VF are a novel ‘functional marker’ for progressive ischaemia.

Key Words: CSI; subarachnoid haemorrhage; cortical spreading depression; neurovascular coupling; default mode

Abbreviations: aSAH, aneurysmal subarachnoid haemorrhage; BOLD, blood oxygen level dependent; COSBID, Cooperative Study on Brain Injury Depolarizations; CSD, cortical spreading depolarization; CSI, cortical spreading ischaemia; CT, computed tomography; DC, direct current; DSA, digital subtraction angiography; ECoG, electrocorticography; GCS, Glasgow Coma Score; HF-ECoG, high-frequency electrocorticogram; HF-VF, high-frequency vascular fluctuations; ICP, intracranial pressure; LDF, laser-Doppler flowmetry; LF-VF, low-frequency vascular fluctuations; MCA, middle cerebral artery; MRI, magnetic resonance imaging; MRS, Modified Rankin Scale; NMDA, N-methyl-D-aspartate; ptiO2, tissue partial pressure of oxygen; rCBF, regional cerebral blood flow; SPC, slow potential change; TCD, transcranial Doppler-sonography; WFNS, World Federation of Neurological Surgeons.

Received December 30, 2008. Revised March 10, 2009. Accepted March 27, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
J. C. Chavez, O. Hurko, F. C. Barone, and G. Z. Feuerstein
Pharmacologic Interventions for Stroke: Looking Beyond the Thrombolysis Time Window Into the Penumbra With Biomarkers, Not a Stopwatch
Stroke, October 1, 2009; 40(10): e558 - e563.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.